SCHEMBL5402499

SCHEMBL5402499

COc1ccc(CCN(CCC(=O)O)C(=O)c2ccccc2-c2ccccc2C(=O)NCc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
RAB9A P51151 2/20 0.53
HPGD P15428 4/20 0.50
SLC6A5 Q9Y345 2/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
NPC1 O15118 2/20 0.49
ALOX5 P09917 2/20 0.47
TP53 P04637 1/20 0.47
GLA P06280 1/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
LPAR1 Q92633 2/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
LPAR5 Q9H1C0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5398082 1.00 ALDH1A1 (0.54) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5399048 0.99 ALDH1A1 (0.52) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5401660 0.95 TP53 (0.49) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5416741 0.95 TP53 (0.49) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5394017 0.95 ALDH1A1 (0.55) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5400829 0.94 KCNK3 (0.49) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5406284 0.94 ALDH1A1 (0.48) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5397871 0.93 RAB9A (0.61) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5406178 0.93 RAB9A (0.64) ALDH1A1RAB9AHPGDSLC6A5HDAC1
SCHEMBL5392894 0.93 POLB (0.50) ALDH1A1RAB9AHPGDSLC6A5HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885RAB9A 3132/4885HPGD 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.